The maker of synthetic DNA for the biotechnology industry posted revenue of $13.6 million in the period, surpassing Street forecasts. Three analysts ...
News
- Twist Bioscience: Fiscal 2Q Earnings Snapshot
- Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding
San Antonio—Emtora Biosciences, a San Antonio biotech startup formerly known as Rapamycin Holdings, is planning to test its drug, eRapa, as a ...
- Amgen: 1Q Earnings Snapshot
The world's largest biotech drugmaker posted revenue of $5.56 billion in the period, which matched Street forecasts. Amgen expects full-year earnings ...
- Form DEF 14A Fortress Biotech, Inc. For: Jun 18
Form DEF 14A Fortress Biotech, Inc. For: Jun 18 .... The Annual Meeting of Stockholders of Fortress Biotech, Inc. will be held at the offices of ..... Professor of Medicine at the University of Texas Health Science Center at San Antonio.
- Higher education notebook
Prior to UALR, he was vice president for business affairs at Texas A&M University-San Antonio, vice chancellor for finance and administration at the ... director of the Arkansas Biosciences Institute to the positions permanently, the ...